Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07241338
Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity (SHOT)
Sacubitril/Allisartan Versus Amlodipine for Hypertensive Patients With Overweight or Obesity: A Multicenter, Open-Label, Randomized Controlled Trial
Sponsor: Jing Liu
Conditions
Hypertension
Interventions
Amlodipine sacubitril/allisartan
Updated 1 time since 2025 Last updated: Nov 16, 2025 Started: Nov 30, 2025 Primary completion: Nov 30, 2026 Completion: Jun 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Hypertension, this trial is actively recruiting participants. The trial is conducted by Jing Liu and has accumulated 1 data snapshot since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jing Liu
Data source: Peking University People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .